Novel Regimens in COVID-19 Treatment

PHASE3RecruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions

COVIDCorona Virus Infection

Interventions

DRUG

Nitazoxanide

Trial Locations (2)

RECRUITING

Tanta University, Assiut University, Tanta

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT04382846 - Novel Regimens in COVID-19 Treatment | Biotech Hunter | Biotech Hunter